BR9911598A - Uso de derivados do ácido 2-hidróxi-4-trifluormetilbenzóico como inibidores da ativação do fator de transcrição nuclear nf-kb - Google Patents
Uso de derivados do ácido 2-hidróxi-4-trifluormetilbenzóico como inibidores da ativação do fator de transcrição nuclear nf-kbInfo
- Publication number
- BR9911598A BR9911598A BR9911598-0A BR9911598A BR9911598A BR 9911598 A BR9911598 A BR 9911598A BR 9911598 A BR9911598 A BR 9911598A BR 9911598 A BR9911598 A BR 9911598A
- Authority
- BR
- Brazil
- Prior art keywords
- hydroxy
- activation
- inhibitors
- trifluoromethylbenzoic acid
- transcription factor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Patente de Invenção: <B>"USO DE DERIVADOS DO áCIDO 2-HIDRóXI-4-TRIFLUORMETILBENZóICO COMO INIBIDORES DA ATIVAçãO DO FATOR DE TRANSCRIçãO NUCLEAR NF- ~ K~B"<D>. A invenção se refere ao uso dos derivados do ácido 2-hidróxi-4-trifluormetil benzóico para a inibição do fator de transcrição NF- ~ k~B. A invenção também se refere ao uso dos derivados do ácido 2-hidróxi-4-trifluormetil benzóico para a fabricação de medicamentos para o tratamento ou a prevenção de patologias associadas à ativação do NF-~ k~B e/ou a expressão de genes dependente e/ou regulada, pelo menos em parte, pelo NF ~ k~B em mamíferos, incluindo seres humanos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES009801154A ES2136581B1 (es) | 1998-05-27 | 1998-05-27 | Uso de derivados del acido-2-hidroxi-4-trifluorometilbenzoico para la preparacion de medicamentos utiles para inhibir el factor de transcripcion nuclear nf-kb. |
| PCT/ES1999/000154 WO1999061030A1 (es) | 1998-05-27 | 1999-05-26 | USO DE DERIVADOS DEL ACIDO 2-HIDROXI-4-TRIFLUOROMETILBENZOICO COMO INHIBIDORES DE LA ACTIVACION DEL FACTOR DE TRANSCRIPCION NUCLEAR NF-λB |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9911598A true BR9911598A (pt) | 2001-02-13 |
Family
ID=8304002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9911598-0A BR9911598A (pt) | 1998-05-27 | 1999-05-26 | Uso de derivados do ácido 2-hidróxi-4-trifluormetilbenzóico como inibidores da ativação do fator de transcrição nuclear nf-kb |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6414025B1 (pt) |
| EP (2) | EP1362592A1 (pt) |
| JP (1) | JP2002516283A (pt) |
| KR (2) | KR100713601B1 (pt) |
| AT (1) | ATE245987T1 (pt) |
| AU (1) | AU3828699A (pt) |
| BR (1) | BR9911598A (pt) |
| CA (1) | CA2332863A1 (pt) |
| DE (1) | DE69910019T2 (pt) |
| DK (1) | DK1082962T3 (pt) |
| ES (2) | ES2136581B1 (pt) |
| NO (1) | NO20005981L (pt) |
| PT (1) | PT1082962E (pt) |
| WO (1) | WO1999061030A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2154242B1 (es) * | 1999-09-03 | 2001-10-16 | Uriach & Cia Sa J | Nuevos sistemas polimericos biocompatibles portadores de triflusal o htb. |
| US20040101488A1 (en) * | 2000-03-24 | 2004-05-27 | Balaram Ghosh | Method for the prevention of septic shock lethality using curcumin |
| ES2190373B1 (es) * | 2001-12-07 | 2004-10-16 | J. URIACH & CIA, S.A. | Uso del acido 2-hidroxi- o 2-acetiloxi-4-trifluorometilbenzoico como agente para el tratamiento y prevencion del deterioro cognitivo ligero. |
| WO2004026406A1 (en) | 2002-09-20 | 2004-04-01 | Alcon, Inc. | Use of cytokine synthesis inhibitors for the treatment of dry eye disorders |
| JP5780521B2 (ja) | 2008-05-28 | 2015-09-16 | リベラジェン・バイオファーマ・インコーポレイテッドＲｅｖｅｒａＧｅｎ ＢｉｏＰｈａｒｍａ，Ｉｎｃ． | 疾患を治療するための、ＮＦ−κＢの非ホルモン性ステロイド調節因子 |
| MX2021012876A (es) | 2009-03-18 | 2022-06-23 | Resverlogix Corp | Nuevos agentes anti-inflamatorios. |
| EP2556083A4 (en) | 2010-04-05 | 2013-12-04 | Validus Biopharma Inc | NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT |
| CN103665012B (zh) * | 2013-12-06 | 2016-06-22 | 辽宁师范大学 | 新型三氟柳无机药物化合物及合成方法 |
| US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
| US20180016314A1 (en) * | 2016-07-12 | 2018-01-18 | Children's Hospital Medical Center | Treatment of disease via transcription factor modulation |
| KR101975603B1 (ko) | 2018-09-14 | 2019-08-28 | 이영문 | 조력 발전장치 |
| US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4096252A (en) * | 1976-06-10 | 1978-06-20 | J. Uriach & Cia S.A. | 4-Trifluoromethylbenzoic acid derivatives as thromboembolic agents |
| IT1276071B1 (it) * | 1995-10-31 | 1997-10-24 | Nicox Ltd | Compositi ad attivita' anti-infiammatoria |
-
1998
- 1998-05-27 ES ES009801154A patent/ES2136581B1/es not_active Expired - Fee Related
-
1999
- 1999-05-26 DK DK99920872T patent/DK1082962T3/da active
- 1999-05-26 WO PCT/ES1999/000154 patent/WO1999061030A1/es active IP Right Grant
- 1999-05-26 KR KR1020007013316A patent/KR100713601B1/ko not_active IP Right Cessation
- 1999-05-26 AU AU38286/99A patent/AU3828699A/en not_active Abandoned
- 1999-05-26 EP EP03012255A patent/EP1362592A1/en not_active Withdrawn
- 1999-05-26 US US09/701,270 patent/US6414025B1/en not_active Expired - Fee Related
- 1999-05-26 AT AT99920872T patent/ATE245987T1/de not_active IP Right Cessation
- 1999-05-26 CA CA002332863A patent/CA2332863A1/en not_active Abandoned
- 1999-05-26 ES ES99920872T patent/ES2204129T3/es not_active Expired - Lifetime
- 1999-05-26 JP JP2000550490A patent/JP2002516283A/ja active Pending
- 1999-05-26 DE DE69910019T patent/DE69910019T2/de not_active Expired - Fee Related
- 1999-05-26 PT PT99920872T patent/PT1082962E/pt unknown
- 1999-05-26 BR BR9911598-0A patent/BR9911598A/pt not_active Application Discontinuation
- 1999-05-26 KR KR1020067026281A patent/KR100762156B1/ko not_active IP Right Cessation
- 1999-05-26 EP EP99920872A patent/EP1082962B1/en not_active Expired - Lifetime
-
2000
- 2000-11-27 NO NO20005981A patent/NO20005981L/no not_active Application Discontinuation
-
2002
- 2002-04-04 US US10/115,140 patent/US6610745B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2136581B1 (es) | 2000-09-16 |
| DK1082962T3 (da) | 2003-11-24 |
| NO20005981L (no) | 2000-12-12 |
| NO20005981D0 (no) | 2000-11-27 |
| JP2002516283A (ja) | 2002-06-04 |
| EP1082962A1 (en) | 2001-03-14 |
| KR100762156B1 (ko) | 2007-10-04 |
| US6610745B2 (en) | 2003-08-26 |
| WO1999061030A1 (es) | 1999-12-02 |
| ES2204129T3 (es) | 2004-04-16 |
| AU3828699A (en) | 1999-12-13 |
| DE69910019T2 (de) | 2004-05-06 |
| US6414025B1 (en) | 2002-07-02 |
| EP1082962B1 (en) | 2003-07-30 |
| PT1082962E (pt) | 2003-11-28 |
| US20030032630A1 (en) | 2003-02-13 |
| KR100713601B1 (ko) | 2007-05-02 |
| ES2136581A1 (es) | 1999-11-16 |
| ATE245987T1 (de) | 2003-08-15 |
| KR20010052404A (ko) | 2001-06-25 |
| CA2332863A1 (en) | 1999-12-02 |
| EP1362592A1 (en) | 2003-11-19 |
| KR20070006943A (ko) | 2007-01-11 |
| DE69910019D1 (de) | 2003-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9611802A (pt) | Composições farmacêuticas | |
| BR9911598A (pt) | Uso de derivados do ácido 2-hidróxi-4-trifluormetilbenzóico como inibidores da ativação do fator de transcrição nuclear nf-kb | |
| AR020633A1 (es) | Parche cosmetico, farmaceutico o dermatologico. | |
| PT921785E (pt) | Combinacao de enzimas protease acidas e tampoes acidicos e suas utilizacoes | |
| NO991685D0 (no) | Anvendelse av 1-benzyl-3-(substituert hetaryl)-kondenserte pyrazolderivater for behandling av spesielle sykdommer i hjerte-kretsl°psystemet og sentralnervesystemet | |
| TR200002355T2 (tr) | 2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri | |
| ME00298B (me) | Farmaceutski preparat | |
| BR0011172A (pt) | Derivados do 4,5-diaril-3(2h)-furanona como inibidores de cliclooxigenase-2 | |
| BR0009814A (pt) | Processo para tratar de uma doença associada com o receptor-beta estrogênico | |
| JP2000503980A5 (pt) | ||
| BRPI0411319A (pt) | compostos terapeuticamente ativos e sua utilização | |
| DE69920757D1 (de) | Immunsuppressive wirkungen von pteridinderivaten | |
| DE69905368T2 (de) | Oxydiertes thymosin beta 4 | |
| BR9911040A (pt) | 2-fenil-1-[4-(2-aminoetóxi)-benzil]-indol em combinação com estrogêneos | |
| SG158916A1 (en) | Nitrooxy derivatives op glucocorticoids | |
| DE69839939D1 (de) | Tropoelastinderivate | |
| BR9916575A (pt) | Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa | |
| AR001790A1 (es) | Formulaciones para parches transdermicos que sirven para el tratamiento de condiciones modeladas de receptores muscarinicos | |
| EP1157698A3 (en) | Treatment of inflammatory diseases with oxypurine nucleosides | |
| BR9707247A (pt) | Diidrobenzofurano e compostos relacionados úteis como agentes antiinflamatórios | |
| DK0825865T3 (da) | Transdermalt, terapeutisk system for administrering af testosteron eller testosteronderivat | |
| WO2000040232A3 (en) | Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
| NO20014081L (no) | Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier | |
| BR0015781A (pt) | Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea | |
| MD1473F2 (en) | Antiherpetic remedy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B25G | Requested change of headquarter approved |
Owner name: J. URIACH AND CIA. S/A (ES) Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020080074822/RJ DE 19/05/2008. |
|
| B25A | Requested transfer of rights approved |
Owner name: PALAU PHARMA, S.A. (ES) Free format text: TRANSFERIDO DE: J. URIACH AND CIA. S/A |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE O MESMO NAO ATENDE AO DISPOSTO NOS ARTGOS 24 E 25 DALPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |